Fibrous Dysplasia Support Society - Charities report - 22.2

Fibrous Dysplasia Support Society - Charities report - 22.2


IRIS Accounts Productionv23.1.0.753OtherCompany accountsTruefalsePounds1.4.2231.3.2331.3.23FYFRS 102Independent examinerLarge and medium-sized companies regime for accountsFullCharities SORPtruetruetruetruefalsetruefalsetrue00 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure103362692022-03-31103362692023-03-31103362692022-04-012023-03-31103362692021-03-31103362692021-04-012022-03-31103362692022-03-3110336269ns0:CharitableCompanyLimitedByGuarantee2022-04-012023-03-3110336269ns15:PoundSterling2022-04-012023-03-3110336269ns11:FRS1022022-04-012023-03-3110336269ns11:IndependentExaminationCharity2022-04-012023-03-3110336269ns11:LargeMedium-sizedCompaniesRegimeForAccounts2022-04-012023-03-3110336269ns11:FullAccounts2022-04-012023-03-3110336269ns11:CharitiesSORP2022-04-012023-03-3110336269ns16:EnglandWales2022-04-012023-03-3110336269ns11:RegisteredOffice2022-04-012023-03-3110336269ns0:Trustee22022-04-012023-03-3110336269ns0:Trustee32022-04-012023-03-3110336269ns0:Trustee12022-04-012023-03-3110336269ns0:Trustee42022-04-012023-03-3110336269ns0:Trustee52022-04-012023-03-3110336269ns0:Trustee62022-04-012023-03-3110336269ns0:Trustee72022-04-012023-03-3110336269ns0:Trustee82022-04-012023-03-3110336269ns0:Trustee92022-04-012023-03-3110336269ns11:MainIndustrySectorHeading2022-04-012023-03-3110336269ns11:MainIndustrySectorHeading2021-04-012022-03-3110336269ns0:TotalUnrestrictedFunds2023-03-311033626922022-04-012023-03-31

REGISTERED COMPANY NUMBER: 10336269 (England and Wales)

REGISTERED CHARITY NUMBER: 1175622















Report of the Trustees and

Financial Statements For The Year Ended 31 March 2023

for


Fibrous Dysplasia Support Society

(A Company Limited by Guarantee)



Fibrous Dysplasia Support Society








Contents of the Financial Statements

For The Year Ended 31 March 2023






Page




Report of the Trustees  

1




Independent Examiner's Report  

2




Statement of Financial Activities  

3




Balance Sheet  

4




Notes to the Financial Statements  

5


to


8



Fibrous Dysplasia Support Society (Registered number: 10336269)



Report of the Trustees

For The Year Ended 31 March 2023



The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 March 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).


STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006.


REFERENCE AND ADMINISTRATIVE DETAILS

Registered Company number

10336269 (England and Wales)


Registered Charity number

1175622


Registered office

82 Nottingham Road

Somercotes

Alfreton

Derbyshire

DE55 4LY


Trustees

H Delaney

H Wall

J Watson

S G Bullock

M K Javaid

S A Russell

J M Ellis

S Richardson

S R J McMurray


Independent Examiner

Pedley & Co.

Chartered Certified Accountants

82 Nottingham Road

Somercotes

Alfreton

Derbyshire

DE55 4LY


Approved by order of the board of trustees on 29 December 2023 and signed on its behalf by:






J Watson - Trustee


Independent Examiner's Report to the Trustees of

Fibrous Dysplasia Support Society


Independent examiner's report to the trustees of Fibrous Dysplasia Support Society ('the Company')

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2023.


Responsibilities and basis of report

As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').


Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.


Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:


1.

accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or

2.

the accounts do not accord with those records; or

3.

the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or

4.

the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).


I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.









Pedley & Co


Pedley & Co.


29 December 2023



Fibrous Dysplasia Support Society



Statement of Financial Activities

For The Year Ended 31 March 2023



2023


2022


Unrestricted


Total


fund


funds


Notes

£   

£   


INCOME AND ENDOWMENTS FROM

Donations and legacies

1,451


8,618



EXPENDITURE ON

Raising funds

-


132



Charitable activities

Conference

730


1,333


Total

730


1,465



NET INCOME

721


7,153




RECONCILIATION OF FUNDS

Total funds brought forward

28,009


20,856



TOTAL FUNDS CARRIED FORWARD

28,730


28,009




Fibrous Dysplasia Support Society (Registered number: 10336269)



Balance Sheet

31 March 2023



2023


2022


Unrestricted


Total


fund


funds


Notes

£   

£   


CURRENT ASSETS


Cash at bank

28,730


28,009



NET CURRENT ASSETS

28,730


28,009



TOTAL ASSETS LESS CURRENT

LIABILITIES

28,730


28,009



NET ASSETS

28,730


28,009


FUNDS

4

Unrestricted funds

28,730


28,009


TOTAL FUNDS

28,730


28,009



The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.


The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.


The trustees acknowledge their responsibilities for
(a)ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.

These financial statements have been prepared in accordance with and delivered in accordance with the special provisions applicable to small charitable companies subject to the small companies regime.




The financial statements were approved by the Board of Trustees and authorised for issue on 29 December 2023 and were signed on its behalf by:






J Watson - Trustee



Fibrous Dysplasia Support Society



Notes to the Financial Statements

For The Year Ended 31 March 2023


1.

ACCOUNTING POLICIES



Basis of preparing the financial statements


The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.



Income


All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.



Expenditure


Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.



Taxation

The charity is exempt from corporation tax on its charitable activities.


Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

2.

TRUSTEES' REMUNERATION AND BENEFITS


There were no trustees' remuneration or other benefits for the year ended 31 March 2023 nor for the year ended 31 March 2022.



Trustees' expenses


There were no trustees' expenses paid for the year ended 31 March 2023 nor for the year ended 31 March 2022.




Fibrous Dysplasia Support Society



Notes to the Financial Statements - continued

For The Year Ended 31 March 2023


3.

COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES


Unrestricted


fund

£   



INCOME AND ENDOWMENTS FROM


Donations and legacies

8,618




EXPENDITURE ON


Raising funds

132




Charitable activities


Conference

1,333



Total

1,465




NET INCOME

7,153





RECONCILIATION OF FUNDS


Total funds brought forward

20,856




TOTAL FUNDS CARRIED FORWARD

28,009



4.

MOVEMENT IN FUNDS


Net




movement


At



At 1/4/22


in funds


31/3/23


£   

£   

£   



Unrestricted funds


General fund

28,009


721


28,730





TOTAL FUNDS

28,009


721


28,730





Net movement in funds, included in the above are as follows:



Incoming


Resources


Movement



resources


expended


in funds


£   

£   

£   



Unrestricted funds


General fund

1,451


(730

)

721





TOTAL FUNDS

1,451


(730

)

721






Fibrous Dysplasia Support Society



Notes to the Financial Statements - continued

For The Year Ended 31 March 2023


4.

MOVEMENT IN FUNDS - continued



Comparatives for movement in funds



Net




movement


At



At 1/4/21


in funds


31/3/22


£   

£   

£   



Unrestricted funds


General fund

20,856


7,153


28,009





TOTAL FUNDS

20,856


7,153


28,009





Comparative net movement in funds, included in the above are as follows:



Incoming


Resources


Movement



resources


expended


in funds


£   

£   

£   



Unrestricted funds


General fund

8,618


(1,465

)

7,153





TOTAL FUNDS

8,618


(1,465

)

7,153





A current year 12 months and prior year 12 months combined position is as follows:



Net




movement


At



At 1/4/21


in funds


31/3/23


£   

£   

£   



Unrestricted funds


General fund

20,856


7,874


28,730





TOTAL FUNDS

20,856


7,874


28,730





A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:



Incoming


Resources


Movement



resources


expended


in funds


£   

£   

£   



Unrestricted funds


General fund

10,069


(2,195

)

7,874





TOTAL FUNDS

10,069


(2,195

)

7,874






Fibrous Dysplasia Support Society



Notes to the Financial Statements - continued

For The Year Ended 31 March 2023


5.

RELATED PARTY DISCLOSURES



There were no related party transactions for the year ended 31 March 2023.